Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled Study.


Journal

The Journal of rheumatology
ISSN: 0315-162X
Titre abrégé: J Rheumatol
Pays: Canada
ID NLM: 7501984

Informations de publication

Date de publication:
07 2019
Historique:
accepted: 08 11 2018
pubmed: 17 3 2019
medline: 22 9 2020
entrez: 17 3 2019
Statut: ppublish

Résumé

To assess cardiac function in patients with juvenile mixed connective tissue disease (JMCTD) compared to matched controls, and to investigate possible associations between cardiac impairment and disease variables and cardiovascular risk factors. Fifty JMCTD patients (86% female) examined median 14.9 (6.6-23.0) years after disease onset were compared with 50 age- and sex-matched controls. Electrocardiogram and echocardiography [including e' as a marker for diastolic dysfunction and long-axis strain (LAS) and left ventricular (LV) ejection fraction (EF) as markers of systolic function] were performed. LV dysfunction (LVD) was defined as low EF, low LAS, or low e'. Right ventricular function was assessed with tricuspid annular plane systolic excursion (TAPSE). Cardiovascular risk factors and disease variables were assessed. LVD was found in 16% of patients and 4% of controls (p = 0.035). EF and LAS were lower in patients compared to controls (6% lower, p < 0.001, and 4% lower, p = 0.044, respectively). TAPSE was 8% lower in patients versus controls (p = 0.008). No patients had signs of pulmonary hypertension. Patients had longer corrected QT time than controls (p = 0.012). LVD was associated with higher levels of apolipoprotein B, higher disease activity measured by physician's global assessment, longer prednisolone treatment, and more organ damage assessed with the Myositis Damage Index. Patients with JMCTD had impaired left and right ventricular function compared to matched controls after median 15 years disease duration. High disease activity and longer treatment with prednisolone were factors associated with LVD.

Identifiants

pubmed: 30877222
pii: jrheum.180526
doi: 10.3899/jrheum.180526
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Prednisolone 9PHQ9Y1OLM

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

739-747

Auteurs

Birgit Nomeland Witczak (BN)

From the Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and the Section of Infectious Diseases, and the Department of Cardiology, Oslo University Hospital - Ullevål; University of Oslo; Department of Rheumatology, Oslo University Hospital - Rikshospitalet; Bjørknes College; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
B.N. Witczak, MD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, Oslo University Hospital - Ullevål, and University of Oslo; S.O. Hetlevik, MD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet; H. Sanner, MD, PhD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet, and Bjørknes College; Z. Barth, MD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, Oslo University Hospital - Ullevål, and University of Oslo, and Bjørknes College, and Department of Translational Medicine, Medical School, University of Pécs; T. Schwartz, MD, PhD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and Section of Infectious Diseases, Oslo University Hospital - Ullevål, and University of Oslo; B. Flatø, MD, PhD, Professor, Department of Rheumatology, Oslo University Hospital - Rikshospitalet, and Faculty of Medicine, Institute of Clinical Medicine, University of Oslo; V. Lilleby, MD, PhD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet; I. Sjaastad, MD, PhD, Professor, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and Department of Cardiology, Oslo University Hospital - Ullevål, and University of Oslo.

Siri Opsahl Hetlevik (SO)

From the Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and the Section of Infectious Diseases, and the Department of Cardiology, Oslo University Hospital - Ullevål; University of Oslo; Department of Rheumatology, Oslo University Hospital - Rikshospitalet; Bjørknes College; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Translational Medicine, Medical School, University of Pécs, Pécs, Hungary. siri.opsahl@gmail.com.
B.N. Witczak, MD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, Oslo University Hospital - Ullevål, and University of Oslo; S.O. Hetlevik, MD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet; H. Sanner, MD, PhD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet, and Bjørknes College; Z. Barth, MD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, Oslo University Hospital - Ullevål, and University of Oslo, and Bjørknes College, and Department of Translational Medicine, Medical School, University of Pécs; T. Schwartz, MD, PhD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and Section of Infectious Diseases, Oslo University Hospital - Ullevål, and University of Oslo; B. Flatø, MD, PhD, Professor, Department of Rheumatology, Oslo University Hospital - Rikshospitalet, and Faculty of Medicine, Institute of Clinical Medicine, University of Oslo; V. Lilleby, MD, PhD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet; I. Sjaastad, MD, PhD, Professor, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and Department of Cardiology, Oslo University Hospital - Ullevål, and University of Oslo. siri.opsahl@gmail.com.

Helga Sanner (H)

From the Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and the Section of Infectious Diseases, and the Department of Cardiology, Oslo University Hospital - Ullevål; University of Oslo; Department of Rheumatology, Oslo University Hospital - Rikshospitalet; Bjørknes College; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
B.N. Witczak, MD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, Oslo University Hospital - Ullevål, and University of Oslo; S.O. Hetlevik, MD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet; H. Sanner, MD, PhD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet, and Bjørknes College; Z. Barth, MD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, Oslo University Hospital - Ullevål, and University of Oslo, and Bjørknes College, and Department of Translational Medicine, Medical School, University of Pécs; T. Schwartz, MD, PhD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and Section of Infectious Diseases, Oslo University Hospital - Ullevål, and University of Oslo; B. Flatø, MD, PhD, Professor, Department of Rheumatology, Oslo University Hospital - Rikshospitalet, and Faculty of Medicine, Institute of Clinical Medicine, University of Oslo; V. Lilleby, MD, PhD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet; I. Sjaastad, MD, PhD, Professor, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and Department of Cardiology, Oslo University Hospital - Ullevål, and University of Oslo.

Zoltan Barth (Z)

From the Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and the Section of Infectious Diseases, and the Department of Cardiology, Oslo University Hospital - Ullevål; University of Oslo; Department of Rheumatology, Oslo University Hospital - Rikshospitalet; Bjørknes College; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
B.N. Witczak, MD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, Oslo University Hospital - Ullevål, and University of Oslo; S.O. Hetlevik, MD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet; H. Sanner, MD, PhD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet, and Bjørknes College; Z. Barth, MD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, Oslo University Hospital - Ullevål, and University of Oslo, and Bjørknes College, and Department of Translational Medicine, Medical School, University of Pécs; T. Schwartz, MD, PhD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and Section of Infectious Diseases, Oslo University Hospital - Ullevål, and University of Oslo; B. Flatø, MD, PhD, Professor, Department of Rheumatology, Oslo University Hospital - Rikshospitalet, and Faculty of Medicine, Institute of Clinical Medicine, University of Oslo; V. Lilleby, MD, PhD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet; I. Sjaastad, MD, PhD, Professor, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and Department of Cardiology, Oslo University Hospital - Ullevål, and University of Oslo.

Thomas Schwartz (T)

From the Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and the Section of Infectious Diseases, and the Department of Cardiology, Oslo University Hospital - Ullevål; University of Oslo; Department of Rheumatology, Oslo University Hospital - Rikshospitalet; Bjørknes College; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
B.N. Witczak, MD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, Oslo University Hospital - Ullevål, and University of Oslo; S.O. Hetlevik, MD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet; H. Sanner, MD, PhD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet, and Bjørknes College; Z. Barth, MD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, Oslo University Hospital - Ullevål, and University of Oslo, and Bjørknes College, and Department of Translational Medicine, Medical School, University of Pécs; T. Schwartz, MD, PhD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and Section of Infectious Diseases, Oslo University Hospital - Ullevål, and University of Oslo; B. Flatø, MD, PhD, Professor, Department of Rheumatology, Oslo University Hospital - Rikshospitalet, and Faculty of Medicine, Institute of Clinical Medicine, University of Oslo; V. Lilleby, MD, PhD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet; I. Sjaastad, MD, PhD, Professor, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and Department of Cardiology, Oslo University Hospital - Ullevål, and University of Oslo.

Berit Flatø (B)

From the Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and the Section of Infectious Diseases, and the Department of Cardiology, Oslo University Hospital - Ullevål; University of Oslo; Department of Rheumatology, Oslo University Hospital - Rikshospitalet; Bjørknes College; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
B.N. Witczak, MD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, Oslo University Hospital - Ullevål, and University of Oslo; S.O. Hetlevik, MD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet; H. Sanner, MD, PhD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet, and Bjørknes College; Z. Barth, MD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, Oslo University Hospital - Ullevål, and University of Oslo, and Bjørknes College, and Department of Translational Medicine, Medical School, University of Pécs; T. Schwartz, MD, PhD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and Section of Infectious Diseases, Oslo University Hospital - Ullevål, and University of Oslo; B. Flatø, MD, PhD, Professor, Department of Rheumatology, Oslo University Hospital - Rikshospitalet, and Faculty of Medicine, Institute of Clinical Medicine, University of Oslo; V. Lilleby, MD, PhD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet; I. Sjaastad, MD, PhD, Professor, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and Department of Cardiology, Oslo University Hospital - Ullevål, and University of Oslo.

Vibke Lilleby (V)

From the Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and the Section of Infectious Diseases, and the Department of Cardiology, Oslo University Hospital - Ullevål; University of Oslo; Department of Rheumatology, Oslo University Hospital - Rikshospitalet; Bjørknes College; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
B.N. Witczak, MD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, Oslo University Hospital - Ullevål, and University of Oslo; S.O. Hetlevik, MD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet; H. Sanner, MD, PhD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet, and Bjørknes College; Z. Barth, MD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, Oslo University Hospital - Ullevål, and University of Oslo, and Bjørknes College, and Department of Translational Medicine, Medical School, University of Pécs; T. Schwartz, MD, PhD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and Section of Infectious Diseases, Oslo University Hospital - Ullevål, and University of Oslo; B. Flatø, MD, PhD, Professor, Department of Rheumatology, Oslo University Hospital - Rikshospitalet, and Faculty of Medicine, Institute of Clinical Medicine, University of Oslo; V. Lilleby, MD, PhD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet; I. Sjaastad, MD, PhD, Professor, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and Department of Cardiology, Oslo University Hospital - Ullevål, and University of Oslo.

Ivar Sjaastad (I)

From the Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and the Section of Infectious Diseases, and the Department of Cardiology, Oslo University Hospital - Ullevål; University of Oslo; Department of Rheumatology, Oslo University Hospital - Rikshospitalet; Bjørknes College; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
B.N. Witczak, MD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, Oslo University Hospital - Ullevål, and University of Oslo; S.O. Hetlevik, MD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet; H. Sanner, MD, PhD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet, and Bjørknes College; Z. Barth, MD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, Oslo University Hospital - Ullevål, and University of Oslo, and Bjørknes College, and Department of Translational Medicine, Medical School, University of Pécs; T. Schwartz, MD, PhD, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and Section of Infectious Diseases, Oslo University Hospital - Ullevål, and University of Oslo; B. Flatø, MD, PhD, Professor, Department of Rheumatology, Oslo University Hospital - Rikshospitalet, and Faculty of Medicine, Institute of Clinical Medicine, University of Oslo; V. Lilleby, MD, PhD, Department of Rheumatology, Oslo University Hospital - Rikshospitalet; I. Sjaastad, MD, PhD, Professor, Institute for Experimental Medical Research and K.G. Jebsen Center for Cardiac Research, and Department of Cardiology, Oslo University Hospital - Ullevål, and University of Oslo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH